The top woman in tennis now backs a genetic sex test that will label every player for life in the name of “fairness.”
Story Snapshot
- World No. 1 Aryna Sabalenka supports the Women’s Tennis Association’s new genetic sex-testing rule.
- The policy blocks transgender women and others with male-linked genes from playing in the women’s tour.
- All women players must give DNA for a one-time test, even though no trans women compete now.
- Supporters say the rule protects fairness; critics warn about privacy, stigma, and elite control over women’s bodies.
What the WTA’s New Rule Does
The Women’s Tennis Association has approved a new eligibility rule that uses genetic testing to decide who can play on the women’s tour. The policy requires every player to give a DNA sample one time to check for the SRY gene, which is linked to male biological development. It replaces an older rule that allowed transgender women to compete if they kept testosterone below a set limit for at least two years. The new standard speaks to a larger trend: sports bodies are moving from hormone rules to stricter sex-based categories.
Under this system, any player who tests positive for the SRY gene can be pushed into further medical review and may be ruled ineligible for women’s events. Genetic experts have warned that this gene alone does not prove someone went through male puberty or has a present physical edge. Some women are born with differences in sex development, such as complete androgen insensitivity, and could be swept into the same process even though they grew up and lived as women. That risk feeds fears that the rule goes far beyond stopping transgender women.
Sabalenka’s Case for “Fairness in Our Circuit”
World No. 1 Aryna Sabalenka has become the loudest active voice backing the new policy. Asked about the rule, she said, “It’s very important to maintain fairness in our circuit,” and called the one-time testing “pretty fair.” She argued that “biologically, men are much stronger than women,” and said it would not be fair for women to compete against “a biological man.” Sabalenka told Piers Morgan she has “nothing against” transgender people, but believes they still have a “huge” or “significant” advantage over women even under hormone limits.
Sabalenka framed the issue in terms many frustrated Americans recognize: women spend their whole lives training within female limits, only to face opponents whose bodies were shaped by male puberty. In her words, “It’s simply unfair. Women have dedicated their entire lives to reach their peak performance, and then they have to compete against a man who possesses biological strength.” She said she would “gladly” take the genetic test herself if that is what it takes to keep the tour fair. For many fans who think past policies bowed to “woke” pressure, her stance looks like a long-delayed correction.
Why Many Players Are Alarmed
The same rule that Sabalenka calls “pretty fair” feels invasive and risky to others on tour. Reports say the Women’s Tennis Association did not explain the change directly to players or release a detailed medical memo with the scientific basis. Critics point out that there are currently no transgender women in top-level Women’s Tennis Association events, yet every woman must provide DNA and accept a lifelong label about her sex. For athletes already wary of big institutions, it looks like another case where leaders act first and only talk to the people affected later.
🎾 Aryna Sabalenka is backing the WTA’s new transgender eligibility policy.
Sabalenka says it is unfair for biological men to compete in women’s tennis, adding that while the WTA “took a little while” to make the decision, she believes it ultimately made the right call.
She… https://t.co/12HYC6nt1K pic.twitter.com/sdBMuDEyMv
— The Globe & News (@TheGlobeNewt) August 4, 2026
Medical privacy and control of one’s own body are at the center of the pushback. A genetic test result can follow a player for years, and many worry who will see that data and how it could be used. Some women fear being misclassified or forced to prove they are “female enough” to keep their jobs. That hits a nerve that crosses party lines: both conservatives and liberals have grown tired of rules handed down by global sports groups or national elites who they feel never really answer to regular people.
A Clash of Fairness, Freedom, and Trust
This fight over one tennis rule echoes a wider struggle in sports and politics. Across leagues, governing bodies are trying to balance open doors for transgender athletes with worries about strength, speed, and fairness in women’s events. Sabalenka’s backing may make the Women’s Tennis Association policy look settled, but as one analysis warns, star support is still opinion, not proof. The harder questions remain: who decides what counts as male or female, how much evidence is enough, and how much power should any institution have over an athlete’s DNA and identity.
For many Americans, the story fits a familiar pattern. A private sports group, led by people far from everyday life, quietly adopts a sweeping rule about bodies and rights. Some stars cheer, others object, and fans are left to guess what really drove the change. Whether you worry more about unfair advantage or about government and corporate elites controlling people’s lives, the Women’s Tennis Association’s new genetic test shows how often both sides’ fears now collide in the same headline.
Sources:
facebook.com, gbnews.com, reuters.com, sports.yahoo.com, youtube.com
